Speaker illustration

Doctor Osung Kwon

Eunpyeong St. Mary's Hospital, Seoul (Korea (Republic of))

Sodium-glucose co-transporter-2 inhibitors after acute myocardial infarction in type 2 diabetes patients: a population-based investigation from South Korea

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Coronary artery disease - Pharmacotherapy 1

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb